Clinical Trial Update: Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors. [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating an inhaled mRNA tumor-associated antigen dry powder vaccine for advanced lung cancer and lung metastasis is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lung Metastasis

Drugs mentioned

• Inhaled mRNA tumor-associated antigen dry powder vaccine

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Advanced Lung Cancer, Lung Metastasis | EARLY_Phase 1 | Status: RECRUITING